logo
logo

Kayo Thera announced it raised $10.5 Million in an amended filing from an offering of $10.9 Million

Kayo Thera announced it raised $10.5 Million in an amended filing from an offering of $10.9 Million

07/13/23, 3:03 PM
Location
https://purecatamphetamine.github.io/country-flag-icons/3x2/US.svgprinceton
Money raised
$10.5 million
Industry
therapeutics
biotechnology
health care

Company Info

Company
KayoThera, Inc.
Location
155 village blvd., suite 130
princeton, west virginia, united states
Additional Info
KayoThera, Inc. is an early-stage therapeutics company focused on the development of first-in-class, oral, small molecule inhibitors of the retinoid pathway. This pathway plays a critical role in a variety of serious diseases, including cardiometabolic diseases and cancer. KayoThera is developing therapies to treat diabetes and late-stage and metastatic cancers including breast, lung, pancreatic, colorectal, brain, and kidney cancers. The company was founded based on discoveries from Dr. Mark Esposito’s post-doctoral research at Princeton University and professor Yibin Kang, Ph.D. For more information, visit www.kayothera.com.

Related People